Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Biolidics
company
About
Biolidics is focused on the development of medical devices to improve cancer diagnostics and patient care.
- Singapore,Central Region,Singapore
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- S$8.66M
- Industries
- Biotechnology,Health Care,Health Diagnostics
- Founded date
- Jan 1, 2009
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- Clearbridge BioMedics Pte Ltd
- Also Known As
- Clearbridge Biomedics
Biolidics is a medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
S$15.26M
Biolidics has raised a total of
S$15.26M
in funding over 2 rounds. Their latest funding was raised on
Jun 28, 2018 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 28, 2018 | Series Unknown | S$6.60M | — | — | — | Detail |
| Mar 13, 2013 | Series B | S$8.66M | 6 |
Vertex Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
6
Biolidics is funded by 6 investors.
Vertex Ventures
and Dark Horse Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Vertex Ventures
|
Yes | Series B |
Dark Horse Investment
|
— | Series B |
BioVeda Capital
|
— | Series B |
|
|
— | Series B |
Spring SEEDS Capital
|
— | Series B |
Vertex Ventures Southeast Asia & India
|
— | Series B |
Employee Profiles
Number of Employee Profiles
4
Biolidics has 4 current employee profiles, including
Board member Joo Hock Chua
Acquisition
Biolidics has acquired 1 organizations. Their most recent acquisition was Biomedical Laboratory on Mar 30, 2020. They acquired Biomedical Laboratory for $2.60M.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Mar 30, 2020
|
Genetics | acquisition | $ 2.60M | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
